Hypertriglyceridemia in patients with chronic renal failure: Possible mechanisms

Kidney International, Supplement

Volumn 63, Issue 84, 2003, Pages

  Prinsen, Berthil H C M T ^a   De Sain van Der Velden, Monique G M ^a   De Koning, Eelco J P ^a   Koomans, Hein A ^a   Berger, Ruud ^a   Rabelink, Ton J ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

ApoB100; Dialysis; Free fatty acids; Renal insufficiency; VLDL

Indexed keywords

CHOLESTEROL; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LIPOPROTEIN; TRIACYLGLYCEROL;

ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY FAILURE; CONFERENCE PAPER; DIALYSIS; DISEASE COURSE; DYSLIPIDEMIA; ENDOTHELIUM; HUMAN; HYPERTRIGLYCERIDEMIA; LIPOPROTEIN BLOOD LEVEL; MORTALITY; PATHOPHYSIOLOGY; PRIORITY JOURNAL; RISK FACTOR; UREMIA; METABOLISM; REVIEW;

HUMANS; HYPERTRIGLYCERIDEMIA; KIDNEY FAILURE, CHRONIC;

EID: 0037406367     PISSN: 00986577     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1523-1755.63.s84.34.x     Document Type: Conference Paper

References (20)

1. LEVIN A, FOLEY RN: Cardiovascular disease in chronic renal insufficiency. Am J Kidney Dis 36:S24-S30, 2000
2. QUASCHNING T, KRANE V, METZGER T, WANNER C: Abnormalities in uremic lipoprotein metabolism and its impact on cardiovascular disease. Am J Kidney Dis 38:S14-S19, 2001
3. CROSS JM, DONALD AE, KHARBANDA R, et al: Acute administration of L-arginine does not improve arterial endothelial function in chronic renal failure. Kidney Int 60:2318-2323, 2001
4. DE KONING EJ, RABELINK TJ: Endothelial function in the post-prandial state. Atheroscler (Suppl 3):11-16, 2002
5. DEIGHAN CJ, CASLAKE MJ, MCCONNELL M, et al: Atherogenic lipoprotein phenotype in end-stage renal failure: Origin and extent of small dense low-density lipoprotein formation. Am J Kidney Dis 35:852-862, 2000
6. ATTMAN PO, SAMUELSSON OG, MOBERLY J, et al: Apolipoprotein B-containing lipoproteins in renal failure: the relation to mode of dialysis. Kidney Int 55:1536-1542, 1999
7. FALLER B, LAMEIRE N: Evolution of clinical parameters and peritoneal function in a cohort of CAPD patients followed over 7 years. Nephrol Dial Transplant 9:280-286, 1994
8. LITTLE J, PHILLIPS L, RUSSELL L, et al: Longitudinal lipid profiles on CAPD: their relationship to weight gain, comorbidity, and dialysis factors. J Am Soc Nephrol 9:1931-1939, 1998
9. VERSCHOOR L, LAMMERS R, BIRKENHAGER JC: Triglyceride turnover in severe chronic non-nephrotic renal failure. Metabolism 27:879-883, 1978
10. CHAN PC, PERSAUD J, VARGHESE Z, et al: Apolipoprotein B turnover in dialysis patients: Its relationship to pathogenesis of hyperlipidemia. Clin Nephrol 31:88-95, 1989
11. WEINTRAUB M, BURSTEIN A, RASSIN T, et al: Severe defect in clearing postprandial chylomicron remnants in dialysis patients. Kidney Int 42:1247-1252, 1992
12. MALMSTROM R, PACKARD CJ, WATSON TD, et al: Metabolic basis of hypotriglyceridemic effects of insulin in normal men. Arterioscler Thromb Vasc Biol 17:1454-1464, 1997
13. SUTHERLAND WH, WALKER RJ, BALL MJ, et al: Cholesterol precursor concentration in plasma from patients with chronic renal failure or kidney grafts. Clin Nephrol 43:392-398, 1995
14. MALMSTROM R, PACKARD CJ, CASLAKE M, et al: Defective regulation of triglyceride metabolism by insulin in the liver in NIDDM. Diabetologia 40:454-462, 1997
15. PACKARD CJ, DEMANT T, STEWART JP, et al: Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions. J Lipid Res 41:305-318, 2000
16. WARWICK GL, PACKARD CJ, DEMANT T, et al: Metabolism of apolipoprotein B-containing lipoproteins in subjects with nephrotic-range proteinuria. Kidney Int 40:129-138, 1991
17. ALVESTRAND A: Carbohydrate and insulin metabolism in renal failure. Kidney Int (Suppl 62):S48-S52, 1997
18. CHAN MK, PERSAUD J, VARGHESE Z, MOORHEAD JF: Pathogenic roles of post-heparin lipases in lipid abnormalities in hemodialysis patients. Kidney Int 25:812-818, 1984
19. DE SAIN-VAN DER VELDEN MG, KAYSEN GA, DE MEER K, et al: Proportionate increase of fibrinogen and albumin synthesis in nephrotic patients: Measurements with stable isotopes. Kidney Int 53:181-188, 1998
20. DE SAIN-VAN DER VELDEN MG, KAYSEN GA, BARRETT HA, et al: Increased VLDL in nephrotic patients results from a decreased catabolism while increased LDL results from increased synthesis. Kidney Int 53:994-1001, 1998